The iconic rise of copyright’s flagship product presented a massive prospect for the market, but its period has lapsed , creating a intricate landscape. Generic versions have flooded the market , cutting into revenues and putting a strain on profit margins . While leading pharmaceutical companies maintain a presence in this sector , the future se